JP2527782B2 - リウマチ性関節炎治療剤 - Google Patents

リウマチ性関節炎治療剤

Info

Publication number
JP2527782B2
JP2527782B2 JP63025564A JP2556488A JP2527782B2 JP 2527782 B2 JP2527782 B2 JP 2527782B2 JP 63025564 A JP63025564 A JP 63025564A JP 2556488 A JP2556488 A JP 2556488A JP 2527782 B2 JP2527782 B2 JP 2527782B2
Authority
JP
Japan
Prior art keywords
rheumatoid arthritis
acid
compound
formula
dimethoxybenzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP63025564A
Other languages
English (en)
Japanese (ja)
Other versions
JPS63216884A (ja
Inventor
ステラ スコームバーグ チャーピング キャロル
Original Assignee
ザ ウエルカム フアウンデーシヨン リミテツド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ザ ウエルカム フアウンデーシヨン リミテツド filed Critical ザ ウエルカム フアウンデーシヨン リミテツド
Publication of JPS63216884A publication Critical patent/JPS63216884A/ja
Application granted granted Critical
Publication of JP2527782B2 publication Critical patent/JP2527782B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP63025564A 1987-02-06 1988-02-05 リウマチ性関節炎治療剤 Expired - Fee Related JP2527782B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8702758 1987-02-06
GB878702758A GB8702758D0 (en) 1987-02-06 1987-02-06 Treatment of disease

Publications (2)

Publication Number Publication Date
JPS63216884A JPS63216884A (ja) 1988-09-09
JP2527782B2 true JP2527782B2 (ja) 1996-08-28

Family

ID=10611861

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63025564A Expired - Fee Related JP2527782B2 (ja) 1987-02-06 1988-02-05 リウマチ性関節炎治療剤

Country Status (11)

Country Link
US (1) US4818759A (OSRAM)
EP (1) EP0279565B1 (OSRAM)
JP (1) JP2527782B2 (OSRAM)
AT (1) ATE70977T1 (OSRAM)
AU (1) AU606128B2 (OSRAM)
CA (1) CA1302273C (OSRAM)
DE (1) DE3867251D1 (OSRAM)
ES (1) ES2039610T3 (OSRAM)
GB (1) GB8702758D0 (OSRAM)
GR (1) GR3003880T3 (OSRAM)
ZA (1) ZA88830B (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229203B (it) * 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
MXPA03007166A (es) * 2001-02-12 2003-11-18 Hoffmann La Roche Pirido-pirimidinas 6-sustituidas.
EP1896035B1 (en) 2004-06-16 2014-10-15 Jack L. Arbiser Carbazole formulations for the treatment of psoriasis and angiogenesis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3322765A (en) * 1963-10-30 1967-05-30 Burroughs Wellcome Co 2, 4-diamino-6-benzylpyrido-(2, 3-d) pyrimidines and method
ZA803539B (en) * 1979-06-14 1982-01-27 Wellcome Found Alkoxybenzylrimidines method for their preparation formulation thereof and their use in medicine
IT1146940B (it) * 1979-06-14 1986-11-19 Wellcome Found Composti 2,4-diamminopirido (2,3-d) pirimidinici dotati di attivita' farmacologica e procedimento per la loro preparazione
ZA861235B (en) * 1985-03-08 1986-10-29 Univ Princeton Pyrido(2,3-d)pyrimidine derivatives
EP0278686A1 (en) * 1987-02-07 1988-08-17 The Wellcome Foundation Limited Pyridopyrimidines methods for their preparation and pharmaceutical formulations thereof
SE9801992D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I

Also Published As

Publication number Publication date
GB8702758D0 (en) 1987-03-11
EP0279565A1 (en) 1988-08-24
AU606128B2 (en) 1991-01-31
CA1302273C (en) 1992-06-02
ES2039610T3 (es) 1993-10-01
GR3003880T3 (OSRAM) 1993-03-16
JPS63216884A (ja) 1988-09-09
EP0279565B1 (en) 1992-01-02
ZA88830B (en) 1989-10-25
AU1135788A (en) 1988-08-11
US4818759A (en) 1989-04-04
DE3867251D1 (de) 1992-02-13
ATE70977T1 (de) 1992-01-15

Similar Documents

Publication Publication Date Title
JP4491136B2 (ja) 関節症を治療するためのファルネシルタンパク質トランスフェラーゼ阻害剤
US3930005A (en) Antiinflammatory agents and their use
JP2018507888A (ja) ニコチンアミドリボシドの結晶形
JPH0788382B2 (ja) 第三ヒドロキシアルキルキサンチン、それらの製造法及びそれを含有する治療剤
US4322411A (en) Anti-inflammatory nucleosides
US4372957A (en) Treatment with dialkoxy pyridopyrimidines
US4512992A (en) Treatment with dialkoxy pyridopyrimidine compounds
JP3436547B2 (ja) 頭蓋脳外傷後の二次的神経細胞損傷および機能疾患を治療するためのキサンチン誘導体の使用
EP0021292B1 (en) Alkoxybenzylpyridopyrimidines, methods for their preparation and pharmaceutical formulations thereof
JP2527782B2 (ja) リウマチ性関節炎治療剤
JP2001515900A (ja) 抗ウイルス薬
JP4552651B2 (ja) 複素環化合物
JP2602456B2 (ja) 子宮内膜症治療剤
JP2567593B2 (ja) イミダゾリジントリオン誘導体及び該化合物を有効成分として含有するアレルギ−性疾患治療剤
EP0220409B1 (en) Gem-dihalo and tetrahalo-1,12-diamino-4,9-diaza-dodecanes
JP2511709B2 (ja) キサントシリンｘモノメチルエ―テル誘導体及びそれを含有する抗腫瘍剤
US4719313A (en) Gem-dihalo and tetrahalo-1,12-diamino-4,9-diaza-dodecanes
US4473571A (en) 8-Substituted-2-(4-pyridinyl)-9H-purin-6-amines and their cardiotonic use
US11945819B1 (en) Dimethyl 7-bromo-1-(4-substituted benzoyl)pyrrolo[1,2-a]quinoline-2,3-dicarboxylates as anti-inflammatory agents
US12187733B1 (en) 5-(Substitutedphenyl)-7-Imino-7,8-Dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as anti-inflammatory agents
CS221527B2 (en) Method of preparation of n-/1-methyl-2-pyrrolidinylmethyl/2,3-dimethoxy-5-methylsulphamoylbenzamide
US4778926A (en) Gem-dihalo and tetrahalo-1,12-diamino-4,9-diaza-dodecanes
EP0365176A1 (en) Ellipticine glycoside derivatives
US4503228A (en) 2-(Pyridinyl)-4,5,6-pyrimidinetriamines
JPH05246850A (ja) 脳循環の自己調節を安定化するためのキサンチン誘導体の使用

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees